DoW Tuberous Sclerosis Complex Exploration-Hypothesis Development Award
This grant funds early-stage, high-risk research ideas in tuberous sclerosis complex without requiring preliminary data, aiming to generate interpretable results and groundbreaking discoveries.
Funder: Dept. of the Army -- USAMRAA
Due Dates: July 23, 2026: Pre-Application (Letter of Intent) | August 6, 2026: Full Application | August 13, 2026: End of Application Verification
Funding Amounts: $2,100,000 total program funding; up to $350,000 total costs per award, max 2 years; ~6 awards expected
Summary: Supports high-risk, innovative research in tuberous sclerosis complex (TSC) without the need for preliminary data.
Key Information: Preliminary data not required; clinical trials are not allowed.
Description
This grant opportunity supports the initial exploration of innovative, high-risk, and potentially groundbreaking concepts in the field of tuberous sclerosis complex (TSC) research. The intent is to generate preliminary data and stimulate new avenues of scientific investigation in TSC. Projects may address mechanistic studies, animal model development, biomarkers, therapeutics, or patient-centered studies relevant to TSC. Applications should be built on a strong scientific rationale and study design, but preliminary data are not required. Clinical trials are not permitted under this mechanism.
